Results 181 to 190 of about 27,388 (276)

A phase 1 study of heat/phenol‐killed, E. coli‐encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP‐123) for the treatment of peanut allergy

open access: green, 2013
Robert A. Wood   +7 more
openalex   +2 more sources

Dietary Supplementation with Nondigestible Oligosaccharides Reduces Allergic Symptoms and Supports Low Dose Oral Immunotherapy in a Peanut Allergy Mouse Model [PDF]

open access: hybrid, 2018
Laura Wagenaar   +8 more
openalex   +1 more source

Pragmatic Low-Dose Oral Immunotherapy for Preschool Children With Peanut Allergy: A Randomised Controlled Trial. [PDF]

open access: yesClin Exp Allergy
O'Sullivan M   +9 more
europepmc   +1 more source

Real-world utilization of Arachis hypogaea for peanut allergy: Patient and provider perspective. [PDF]

open access: yesJ Allergy Clin Immunol Pract, 2023
Magnarelli A   +4 more
europepmc   +1 more source

Efficacy and safety of oral immunotherapy in children aged 1–3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study

open access: green
Stacie M. Jones   +26 more
openalex   +1 more source

Home - About - Disclaimer - Privacy